Endogamy and Genetic Disorders

Endogamy is the practice of choosing marriage partners within a defined social, ethnic, religious or geographical group. Across generations, restricted gene flow makes members more likely to share alleles inherited from common ancestors, influencing the frequency and geographical clustering of inherited disorders. Its effects are strongest for autosomal recessive disorders, but depend on which variants are present in the group.

Genetic mechanisms

Endogamy does not itself create a disease-causing mutation. It changes the probability that existing variants will be inherited together.

• Restricted mating can increase homozygosity, making it more likely that a child receives two copies of the same recessive disease-causing allele.
• A founder effect can make a rare allele relatively common when a population descends from a small number of founders.
• In a small or isolated population, genetic drift can randomly increase or decrease allele frequencies over generations.
• Consanguinity specifically means reproduction between biological relatives; it may intensify these effects but is not identical to endogamy.

Pattern of inherited disorders

The resulting disease burden is often population-specific rather than uniform. Different endogamous groups may have different founder variants and therefore different carrier frequencies and disorder profiles.

• A recessive disorder becomes more frequent only when the relevant harmful allele is sufficiently common and two carriers have children.
• Endogamy can produce clusters of particular disorders within communities while the same disorders remain uncommon elsewhere.
• Most members of an endogamous population are not necessarily affected; risk varies with carrier status, ancestry and the degree of reproductive isolation.

Relevance for genomic databases

Reliable interpretation requires genomic reference data that represent diverse populations. A variant that is rare globally may be relatively common within a particular group, while an apparently novel variant may simply be absent from an unrepresentative database.

• Population-representative allele-frequency databases help distinguish common benign variation from potentially disease-causing variants.
• Group-specific evidence can improve carrier screening, diagnosis and genetic counselling, provided that consent, privacy and non-stigmatising communication are maintained.